The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study

Table 3 Disease activity in IBD anemic (Group B and C) and non-anemic patients (Group A)

Characteristics	Anemic patients Group B and C (N = 687)	Non-anemic patients Group A (N = 707)	p
Disease activity (clinically judged)^a (%)	382 (55.6%)	176 (24.9%)	< 0.0001
Median CRP^a mg/dl	2.00 (0.50–7.00)	0.40 (0.14–1.3)	< 0.0001
Median SIBDQ^a	50 (39–60)	61 (51–67)	< 0.0001
Median HBI^a	5 (3–7)	3 (1–4)	< 0.0001
Median SCCAI^a	5 (3–8)	1 (0–4)	< 0.0001
Median Ferritin^a ng/ml	23.03 (10–65.9)	70 (39–113.2)	< 0.0001

Group A never anemic patients, Group B episodically anemic patients, Group C recurrently/persistently anemic patients
CRP, C-Reactive Protein; SIBDQ, Simple Inflammatory Bowel Disease Questionnaire; HBI, Harvey-Bradshaw Index; SCCAI, Simple Colitis Activity Index
^aAt entry

ISSN: 1471-230X